[Use of selective inhibitors for computer modeling of the monoamine oxidase active site]. 1997

A V Veselovskiĭ, and A S Ivanov, and A E Medvedev
Institute of Biomedical Chemistry, Moscow, Russia.

Monoamine oxidase (MAO) is an integral protein of the outer mitochondrial membrane, catalysing the reaction of oxidative deamination of monoamines in the central nervous system and peripheral tissues. The present paper reviews data on the structure of MAO, approaches and methods of computer modeling of active site structure, based on the analysis of MAO inhibition by selective inhibitors Flexible molecules, possessing many conformers are useless for computer modeling. Competitive fully reversible MAO inhibitors with rigid structure and limited number of conformers are preferential compounds for these studies.

UI MeSH Term Description Entries
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

A V Veselovskiĭ, and A S Ivanov, and A E Medvedev
January 2000, Neurobiology (Budapest, Hungary),
A V Veselovskiĭ, and A S Ivanov, and A E Medvedev
January 2003, Inflammopharmacology,
A V Veselovskiĭ, and A S Ivanov, and A E Medvedev
March 1976, British journal of pharmacology,
A V Veselovskiĭ, and A S Ivanov, and A E Medvedev
August 2000, Biochemistry. Biokhimiia,
A V Veselovskiĭ, and A S Ivanov, and A E Medvedev
December 2003, Journal of medicinal chemistry,
A V Veselovskiĭ, and A S Ivanov, and A E Medvedev
April 1965, Lancet (London, England),
A V Veselovskiĭ, and A S Ivanov, and A E Medvedev
April 2009, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
A V Veselovskiĭ, and A S Ivanov, and A E Medvedev
February 1971, The Biochemical journal,
A V Veselovskiĭ, and A S Ivanov, and A E Medvedev
August 1963, Life sciences (1962),
A V Veselovskiĭ, and A S Ivanov, and A E Medvedev
July 1984, The Journal of clinical psychiatry,
Copied contents to your clipboard!